Risk adjustment effect on stroke clinical trials.

Stroke; a journal of cerebral circulation

Volumn 35, Issue 2, 2004, Pages

  Johnston, Karen C ^a   Connors Jr , Alfred F ^a   Wagner, Douglas P ^a   Haley Jr , E Clarke ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GLASGOW OUTCOME SCALE; HOSPITALIZATION; HUMAN; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

AGED; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; GLASGOW OUTCOME SCALE; HUMANS; MODELS, STATISTICAL; ODDS RATIO; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RISK ASSESSMENT; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

MLCS; MLOWN;

EID: 1642602685     PISSN: None     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.str.0000109768.98392.4d     Document Type: Article

References (0)